Has given written informed consent before any study-related activity is performed
Advanced hormone-dependent prostate cancer for which androgen deprivation therapy is indicated, and independently from this trial, FirmagonÂ® is intended to be used for treatment
Age greater than or equal to 18 years and less than 80 years
Advanced hormone-dependent prostate cancer without any other clinically significant disorder
Easten Cooperative Oncology Group score = 2
PSA = 2 ng/mL at screening
Life expectancy of at least 12 months as per the investigator's judgement
